Point mutations in topoisomerase I alter the mutation spectrum in E. coli and impact the emergence of drug resistance genotypes.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
24 01 2020
Historique:
accepted: 21 11 2019
revised: 27 09 2019
received: 24 05 2019
pubmed: 30 11 2019
medline: 19 3 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Identifying the molecular mechanisms that give rise to genetic variation is essential for the understanding of evolutionary processes. Previously, we have used adaptive laboratory evolution to enable biomass synthesis from CO2 in Escherichia coli. Genetic analysis of adapted clones from two independently evolving populations revealed distinct enrichment for insertion and deletion mutational events. Here, we follow these observations to show that mutations in the gene encoding for DNA topoisomerase I (topA) give rise to mutator phenotypes with characteristic mutational spectra. Using genetic assays and mutation accumulation lines, we find that point mutations in topA increase the rate of sequence deletion and duplication events. Interestingly, we observe that a single residue substitution (R168C) results in a high rate of head-to-tail (tandem) short sequence duplications, which are independent of existing sequence repeats. Finally, we show that the unique mutation spectrum of topA mutants enhances the emergence of antibiotic resistance in comparison to mismatch-repair (mutS) mutators, and leads to new resistance genotypes. Our findings highlight a potential link between the catalytic activity of topoisomerases and the fundamental question regarding the emergence of de novo tandem repeats, which are known modulators of bacterial evolution.

Identifiants

pubmed: 31777935
pii: 5645004
doi: 10.1093/nar/gkz1100
pmc: PMC6954433
doi:

Substances chimiques

Escherichia coli Proteins 0
Carbon Dioxide 142M471B3J
MutS DNA Mismatch-Binding Protein EC 3.6.1.3
DNA Topoisomerases, Type I EC 5.99.1.2
topA protein, E coli EC 5.99.1.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

761-769

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Genetics. 2016 Nov;204(3):1249-1266
pubmed: 27646140
Mol Biol Evol. 2018 Oct 1;35(10):2414-2421
pubmed: 29939310
Mol Microbiol. 2006 Feb;59(3):723-30
pubmed: 16420346
Cell. 2016 Jun 30;166(1):115-25
pubmed: 27345370
Nucleic Acids Res. 2015 Oct 30;43(19):9306-13
pubmed: 26271994
PLoS Genet. 2014 Aug 07;10(8):e1004543
pubmed: 25102178
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2774-83
pubmed: 22991466
Genetics. 2018 Aug;209(4):1029-1042
pubmed: 29907647
DNA Res. 2005;12(5):291-9
pubmed: 16769691
Nucleic Acids Res. 2013 May;41(9):e98
pubmed: 23470993
PLoS Genet. 2013;9(1):e1003167
pubmed: 23326242
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E5990-9
pubmed: 26460006
Science. 2000 May 19;288(5469):1251-4
pubmed: 10818002
Genetics. 2005 Feb;169(2):523-32
pubmed: 15489515
Nucleic Acids Res. 2019 Mar 18;47(5):2389-2401
pubmed: 30590793
Drug Resist Updat. 2003 Jun;6(3):137-45
pubmed: 12860461
Methods Mol Biol. 2014;1151:165-88
pubmed: 24838886
Nat Commun. 2017 Nov 22;8(1):1705
pubmed: 29167457
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):222-7
pubmed: 23248287
BMC Microbiol. 2012 Feb 28;12:26
pubmed: 22373098
FEMS Microbiol Rev. 2014 Jan;38(1):119-41
pubmed: 23927439
Mutat Res. 2006 Jun 25;598(1-2):144-63
pubmed: 16519906
BMC Biochem. 2009 Jun 11;10:18
pubmed: 19519900
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6939-44
pubmed: 21482796
Nucleic Acids Res. 2019 Jan 8;47(D1):D1164-D1171
pubmed: 30357390
Science. 1996 Nov 15;274(5290):1208-11
pubmed: 8895473
Nucleic Acids Res. 2005 Feb 24;33(4):e36
pubmed: 15731329
Nature. 1997 Jun 12;387(6634):703-5
pubmed: 9192894
Mol Biol Evol. 1987 May;4(3):203-21
pubmed: 3328815
Genome Res. 2012 Jan;22(1):115-24
pubmed: 22080491
FEMS Microbiol Rev. 2009 May;33(3):539-71
pubmed: 19396957
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7266-71
pubmed: 27307441
PLoS One. 2016 Sep 27;11(9):e0162921
pubmed: 27677184
Annu Rev Microbiol. 1996;50:625-43
pubmed: 8905093

Auteurs

Amit Bachar (A)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.

Elad Itzhaki (E)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.

Shmuel Gleizer (S)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.

Melina Shamshoom (M)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.

Ron Milo (R)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.

Niv Antonovsky (N)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, NY 10065, USA.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis
Populus Soil Microbiology Soil Microbiota Fungi

Classifications MeSH